178 related articles for article (PubMed ID: 33960283)
1. Identification of biomarkers related to Tumor-Infiltrating Lymphocytes (TILs) infiltration with gene co-expression network in colorectal cancer.
Liao R; Ma QZ; Zhou CY; Li JJ; Weng NN; Yang Y; Zhu Q
Bioengineered; 2021 Dec; 12(1):1676-1688. PubMed ID: 33960283
[TBL] [Abstract][Full Text] [Related]
2. Three Potential Tumor Markers Promote Metastasis and Recurrence of Colorectal Cancer by Regulating the Inflammatory Response: ADAM8, LYN, and S100A9.
Liu J; Li J; Du H; Xu L; Yang Z; Yuan M; Zhang K; Li J; Xing W; Wang S; Hu T; Wang J; Wang J; Gong Q
Comput Math Methods Med; 2022; 2022():3118046. PubMed ID: 35103068
[TBL] [Abstract][Full Text] [Related]
3. CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
Peng QH; Wang CH; Chen HM; Zhang RX; Pan ZZ; Lu ZH; Wang GY; Yue X; Huang W; Liu RY
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33579737
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
[TBL] [Abstract][Full Text] [Related]
5. Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas.
Zhang Y; Luo J; Liu Z; Liu X; Ma Y; Zhang B; Chen Y; Li X; Feng Z; Yang N; Feng D; Wang L; Song X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34308980
[TBL] [Abstract][Full Text] [Related]
6. Expression of A disintegrin and metalloprotease 8 is associated with cell growth and poor survival in colorectal cancer.
Yang Z; Bai Y; Huo L; Chen H; Huang J; Li J; Fan X; Yang Z; Wang L; Wang J
BMC Cancer; 2014 Aug; 14():568. PubMed ID: 25098630
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
[TBL] [Abstract][Full Text] [Related]
8. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
Liang Z; Li X
Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer.
Zou Q; Wang X; Ren D; Hu B; Tang G; Zhang Y; Huang M; Pai RK; Buchanan DD; Win AK; Newcomb PA; Grady WM; Yu H; Luo Y
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34548385
[TBL] [Abstract][Full Text] [Related]
10. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.
Zhao C; Chen J; Liu Y; Ju S; Wang G; Wang X
Bioengineered; 2021 Dec; 12(2):11648-11661. PubMed ID: 34699318
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer.
Yu L; Yang X; Xu C; Sun J; Fang Z; Pan H; Han W
Int Immunopharmacol; 2020 Dec; 89(Pt B):107077. PubMed ID: 33068862
[TBL] [Abstract][Full Text] [Related]
12. Differential gene expression of tumor-infiltrating CD8
Saleh R; Sasidharan Nair V; Toor SM; Taha RZ; Murshed K; Al-Dhaheri M; Khawar M; Petkar MA; Abu Nada M; Al-Ejeh F; Elkord E
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948653
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and Immunological Role of THBS2 in Colorectal cancer.
Deng B; Liu XP; Wang X
Biomed Res Int; 2021; 2021():1124985. PubMed ID: 34471634
[TBL] [Abstract][Full Text] [Related]
14. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
15. ITGAE Defines CD8+ Tumor-Infiltrating Lymphocytes Predicting a better Prognostic Survival in Colorectal Cancer.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
EBioMedicine; 2018 Sep; 35():178-188. PubMed ID: 30100393
[TBL] [Abstract][Full Text] [Related]
16. SPOCK1 and POSTN are valuable prognostic biomarkers and correlate with tumor immune infiltrates in colorectal cancer.
Gan C; Li M; Lu Y; Peng G; Li W; Wang H; Peng Y; Hu Q; Wei W; Wang F; Liu L; Zhao Q
BMC Gastroenterol; 2023 Jan; 23(1):4. PubMed ID: 36611136
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel lymphangiogenesis signature associated with immune cell infiltration in colorectal cancer based on bioinformatics analysis.
Liu H; Shi H; Sun Y
BMC Med Genomics; 2024 Jan; 17(1):2. PubMed ID: 38167072
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
20. Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker.
Wang L; Liu X; Liu Z; Wang Y; Fan M; Yin J; Zhang Y; Ma Y; Luo J; Li R; Zhao X; Zhang P; Zhao L; Fan J; Chen Y; Lu W; Song X
Sci Rep; 2022 Jan; 12(1):192. PubMed ID: 34996995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]